Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Seattle Genetics kicks off new study in renal cell carcinoma

Aug. 27, 2012

New everolimus formulation approved in Japan

Aug. 27, 2012

Novartis reports new mTOR/PI3K inhibitors

Aug. 27, 2012

New inhibitors of V600E-mutant B-raf presented

Aug. 27, 2012

PCI Biotech selects next indication for Amphinex

Aug. 24, 2012

Research at U.S. university yields new MAT 2 inhibitors

Aug. 24, 2012

Enrollment and dosing begin in first-in-human AT-001 trial

Aug. 24, 2012

OXiGENE and Azanta expand Zybrestat agreement

Aug. 23, 2012

Kyowa Hakko Kirin launches pivotal mogamulizumab trial

Aug. 23, 2012

Novel candidate anticancer drugs synthesized in U.S.

Aug. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...